CDCA8 and aurora kinase B (AURKB) are overexpressed in tumor cells (39,40) and selective suppression of the CDCA8-AURKB pathway may be a promising therapeutic strategy in the treatment of cancer (41). The gene discussed is AURKB; the disease is cancer.